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Summary
Objective: To study quality of life in patients treated for advanced hypopharyngeal or laryngeal
cancer, with laryngeal conservation or laryngectomy.
Patients and methods: A retrospective 2-center study included 100 patients in remission from
squamous cell carcinoma, treated between 1998 and 2009. Seventy patients (24 hypopharynx,
46 larynx) were treated by total (pharyngo-) laryngectomy followed by external radiation
therapy, and 30 (13 hypopharynx, 17 larynx) underwent an organ-conservation protocol with
concurrent radiochemotherapy or with induction chemotherapy using platin-5FU or taxan-
platin-5FU followed by radiation therapy. All patients responded to the quality of life
questionnaires (EORTC QLQ-C30 and QLQ-H&N35).
Results: Advanced tumor stages IVa and IVb were signiﬁcantly more frequent in the surgery
groups (hypopharynx: 71.6% vs. 45.9%, p = 0.01; larynx: 72.4% vs. 37.5%, p < 0.01). In pharyngeal
cancer, the only signiﬁcant difference between surgical treatment and laryngeal conserva-
tion was for ‘‘sensory disorder’’ (taste and odor), with better results in case of laryngeal
conservation (p < 0.0001). For the other items, there was a trend for quality of life to appear
better in patients with laryngeal conservation (p =NS). In laryngeal cancer, the only signiﬁ-
cant difference was for ‘‘dry mouth’’, which was signiﬁcantly less invalidating with surgical
treatment (p < 0.001). The impairment of the other quality of life items did not differ between
surgical and conservative treatment.
Conclusions: Quality of life is impaired in all patients treated for pharyngeal or laryngeal cancer.
The type of treatment, surgical or conservative, affects differently various aspects of quality
of life.
© 2011 Elsevier Masson SAS. All
∗ Corresponding author. Tel.: +33 5 67 77 17 88.
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urative treatment of advanced-stage laryngeal and
ypopharyngeal squamous cell carcinoma classically
served.
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pQuality of life in patients treated for advanced hypopharyng
consists in total (pharyngo-) laryngectomy, resulting in
deﬁnitive tracheostoma and voice loss. The alternative
to this mutilating attitude is concurrent or sequential
radiochemotherapy, conserving the pharyngolaryngeal
organ. Its feasibility and efﬁcacy in organ conservation
and oncologic control have been demonstrated [1—4].
However, these studies did not assess patient quality
of life (QoL), simply trusting that not sacriﬁcing the
larynx is bound to be good for QoL. Yet the secondary
effects of chemotherapy and radiation probably also
impair QoL. The present study therefore compared QoL
in advanced pharyngeal and laryngeal cancer patients
managed on an organ-conservation protocol or by total
(pharyngo-) laryngectomy followed by external radiation
therapy.
Patients and methods
Population characteristics
One hundred and eleven laryngeal or hypopharyngeal squa-
mous cell carcinoma patients treated between 1998 and
2009 and currently in clinical remission were included in
a retrospective study. Locoregional or remote evolution
or recurrence were exclusion criteria. Treatment by total
(pharyngo-) laryngectomy or on an organ-conservation pro-
tocol was decided upon in a multidisciplinary coordination
meeting.
Total laryngectomy was systematically backed up
by external radiation therapy (44—75Gy), with adjuvant
chemotherapy in 31 patients. Successive organ-conservation
protocols were implemented over the study period:
platinum-5ﬂuorouracile (PF) induction chemotherapy,
concurrent radiochemotherapy, and docetaxel-platinum-
5ﬂuorouracile (TPF) induction chemotherapy. Induction
chemotherapy was followed by external radiation therapy in
responsive patients. Patients initially managed by induction
chemotherapy but then undergoing salvage laryngectomy
were included in the surgery group.
Sixty-three of the 69 laryngeal cancer patients ﬁlled out
the QoL questionnaire. Forty-six had undergone total laryn-
gectomy and 17 an organ-conservation protocol (three by
PF, 10 by TPF and four by concurrent radiochemotherapy).
Thirty-seven of the 43 hypopharyngeal cancer patients ﬁlled
out the QoL questionnaire Twenty-four had undergone total
laryngectomy and 13 an organ-conservation protocol (six by
PF, ﬁve by TPF and two by concurrent radiochemotherapy).
Two laryngeal cancer patients who had received conserva-
tive treatment underwent tracheotomy. There were no cases
of gastrostomy.
The study was thus ﬁnally performed on 100 patients.
For the two locations taken together, tumors were mainly
stage III (29%) or IVa (56%). The QoL questionnaire was sent
to the patients least 1 year after treatment termination,
and responses were collected by mail, in consultation or by
telephone.Quality of life assessment
The study used the European Organization for Research and
Treatment of Cancer (EORTC) questionnaire. This consists of
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generic section (QLQ-C30) comprising six functional scales
physical, social, emotional, cognitive, role and general
tatus), three symptom scales (fatigue, pain, nausea and
omiting) and six independent items (dyspnea, insomnia,
ppetite, constipation, diarrhea and ﬁnancial difﬁculties).
he speciﬁc head and neck cancer module (QOL-H&N35)
omprises seven symptom scales (pain, swallowing, senses,
peech, social eating, social contact and sexuality) and nine
ndependent items (teeth, opening mouth, dry mouth, thick
aliva, cough, feeling ill, pain killers, nutritional supple-
ents, feeding probe and weight gain and loss). Each scale
nd item is scored 0—100 after linear transformation. The
unctional scale scores are inverse: i.e., the higher the
core, the better the function; on the symptom scales and
ndependent items, the higher the score, the greater the
ifﬁculties or symptoms.
tatistical analysis
ata were collected separately for laryngeal and hypopha-
yngeal cancer patients. Analysis used Stata SE 11.0
oftware. Quantitative variables were described as mean,
tandard deviation and median. Qualitative variables were
escribed as number and percentage. Demographic and
edical variables were compared between treatment
roups by Khi2, Fisher’s exact or Student t test. QoL scores
ere compared between groups by Wilcoxon or Fisher’s
xact test with Bonferroni correction. The signiﬁcance
hreshold was set at p < 0.0015.
esults
aryngeal cancer
atients in the organ conservation group tended to be
ounger, but without signiﬁcant difference. Stage IV was
igniﬁcantly more common in the surgery group (p < 0.002)
Table 1).
The median interval between end of treatment and
esponse to the QoL questionnaire was 3 years (in both
roups: range, 12 months to 11 years).
Responses on the generic questionnaire (C30) showed
o signiﬁcant differences according to treatment group
Table 2). The trend most closely approximating signiﬁcance
as on the independent item ‘‘insomnia’’ (p = 0.04) (Fig. 1),
ith higher scores in the surgery group: 33 point difference
etween the medians of the two groups.
Responses on the speciﬁc questionnaire (H&N35) showed
signiﬁcant difference on the independent item ‘‘dry
outh’’ (p < 0.001), with higher scores in the conservative
roup (Fig. 1). Another difference approximating signiﬁ-
ance (p = 0.02) was on the ‘‘sticky saliva’’ item, with a
endency toward greater severity in the conservative group:
3 point difference between the medians of the two groups.
he difference in medians between the two groups was 50
oints on the ‘‘senses problems’’ item, with a tendency
oward greater severity in the surgery group, although this
esult did not reach signiﬁcance (p = 0.02). On the other
peciﬁc questionnaire items, there were no signiﬁcant dif-
erences according to treatment group.
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Table 1 Demographic characteristics of patient subgroups.
Characteristics Larynx Hypopharynx
Surgery Conservation Surgery Conservation
Mean age (SD) 61 (10) 58 (7.2) 60 (11) 56 (10.5)
Sex, number
Male 42 13 21 10
Female 4 4 3 3
Stage (%)
I, II or III 27.6% 62.5% 28.4% 54.1%
IVa or IVb 72.4% 37.5% 71.6% 45.9%
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[p = 0.002
ypopharyngeal cancer
ypopharyngeal cancer showed the same age
nd tumor-stage distributions as laryngeal cancer
Table 1).
The median interval between end of treatment and
esponse to the QoL questionnaire was 4 years (range,
2 months to 11 years): 3 years 5 months in the
urgery group, and 4 years 2 months in the conservative
roup.
On the generic questionnaire, there were tendencies
oward signiﬁcance on the ‘‘general status’’ (p = 0.10),
‘physical functioning’’ (p = 0.07) and ‘‘emotional function-
ng’’ (p = 0.05) scales, in the direction of better quality of
ife in the conservative group (differences between median
cores: 17, 7 and 21 points, respectively) (Table 2). On the
ther questionnaire items there were no signiﬁcant differ-
nces according to treatment group.
Responses on the speciﬁc questionnaire showed a signiﬁ-
ant difference on the ‘‘senses problems’’ item (p < 0.001),
ith greater severity in the surgical group and a 66
oint difference between the medians. Another difference
pproximating signiﬁcance was on the ‘‘social eating’’ item
p = 0.02), with a tendency toward greater difﬁculty in the
urgery group: 37 point difference between medians (Fig. 2).
n the other questionnaire items there were no signiﬁ-
ant differences according to treatment group, although
he distribution of scores tended fairly systematically to
e in favor of the conservative group. Weight gain tended
o be more often observed in the conservative group (54%
c
c
s
t
Table 2 Functional scale (QLQ-C30) scores according to surgical
the quality of life.
Score: median (SD) Larynx
Surgery Conservation
General status 66 (25.3) 75 (24.5)
Physical 87 (16.6) 87 (20.8)
Role 100 (26.6) 66 (30.1)
Emotion 75 (24.0) 75 (27.5)
Cognition 84 (19.7) 100 (24.6)
Social 84 (32.1) 84 (35.4)p = 0.01
s. 21%), although the difference did not reach signiﬁcance
p = 0.07).
iscussion
ssessment of change in quality of life in head and neck
ancer used to be restricted to voice and swallowing dis-
rders [5]. More complete measurement tools have now
een available for a number of years, enabling overall
oL impact to be assessed. QoL questionnaires are of two
orts: generic and speciﬁc [6]. Generic tools assess the
verall impact of health status, covering global functional
imensions such as the physical, social and psychological
omains. Their drawback lies in their failure to spotlight
articular aspects of certain pathological processes. Spe-
iﬁc tools can compare patients with a given pathology, and
heir sensitivity enables change in cancer patients’ health
tatus to be detailed over time. Assessment of head and
eck cancer treatment effects requires speciﬁc tools, given
he speciﬁc disorders of voice, swallowing and sensation
s well as issues of physical appearance induced in these
atients. For certain treatments, such as radiation therapy,
peciﬁc tools have been developed to assess consequences
7].
The present study used the EORTC QoL questionnaire,
omprising a generic (QLQ-C30) [8] and head and neck
ancer-speciﬁc section (QLQ-H&N35) [9]. Its validity and
peciﬁcity have been demonstrated. Combined use of the
wo sections has been validated in a study of head and neck
vs. conservative treatment. The higher the scope, the better
Hypopharynx
p Surgery Conservation p
0.99 66 (20.4) 83 (20.3) 0.10
0.31 80 (22.6) 87 (25.4) 0.07
0.33 84 (30.8) 84 (33.0) 0.84
0.91 70.5 (32.5) 92 (30.4) 0.05
0.94 84 (21.2) 84 (30.6) 0.81
0.60 84 (24.4) 100 (32.0) 0.15
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Figure 1 Symptom scale (QLQ-C30, a) and independent item (QLQ-H&N35, b) scores in non-conservative surgical (NC) versus
conservative (C) treatment of laryngeal cancer. Boxes represent 25th and 75th percentiles, and median. The lower the score, the
ow r
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Signiﬁcant difference, p < 0.0015 (0.05 decision threshold, with
cancer patients in 12 countries [10]: it was shown that the
speciﬁc section provided information that the generic sec-
tion could not assess.
The present study identiﬁed certain differences in
quality of life between patients managed by total
(pharyngo-) laryngectomy or with organ conservation. In
laryngeal cancer, patients managed by sequential or concur-
rent radiochemotherapy showed greater symptoms of dry
mouth and thick saliva than those undergoing comple-
mentary radiation therapy following total laryngectomy,
probably due to accumulation of toxicity. Conversely, in
hypopharyngeal cancer, patients managed by total pharyn-
golaryngectomy reported greater difﬁculties in taste and
smell (sensory disorder). These ﬁndings show that each type
of pharyngolaryngeal cancer treatment impacts different
aspects of quality of life.
The literature contains contradictory reports compar-
ing QoL following radiochemotherapy or laryngectomy in
laryngeal cancer. The former is associated with signiﬁ-
cantly better QoL according to Boscolo-Rizzo et al. [11],
whereas Hanna et al. [6] found no signiﬁcant difference.
The present results also found no difference between treat-
ment groups on the social aspects of QoL, except for a
i
t
r
desponse homogeneity.
erroni correction).
endency in hypopharyngeal cancer for ‘‘social eating’’ to
e easier following conservative treatment. Physical change
nd change in self-image, difﬁculty in communication and
ocial isolation following total laryngectomy may impair
uality of life [12], but the present results showed lit-
le such impairment, and did not highlight the possible
irect relation between physical deﬁcit and social implica-
ions. Either patients adapted well to total laryngectomy, or
adiochemotherapy induced just as severe deﬁcits and social
mpact.
More precisely, no difference between treatment groups
merged with respect to voice and swallowing disorder.
linical experience would have suggested greater differ-
nces, with more severe voice disorder associated with
aryngectomy and more severe swallowing disorder with
adiochemotherapy. Other authors, however, using other
oL assessment tools, reported a similar absence of dif-
erence [13,14]. Several factors may explain this. It could
estify to the effectiveness of vocal rehabilitation in
ntensive postoperative speech therapy (esophageal and
racheoesophageal voice training). Secondly, as external
adiation therapy was in fact used in both treatment groups,
ifferences in associated complications such as dysphagia
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Figure 2 Symptom scale (QLQ-C30, a) and independent item (QLQ-H&N35, b) scores in non-conservative surgical (NC) versus
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Conservative (C) treatment of hypopharyngeal cancer. Boxes rep
he better the quality of life. The off-center median indicates
igniﬁcant difference, p < 0.0015 (0.05 decision threshold, with
ay be difﬁcult to highlight. Finally, QoL was assessed at
east 1 year after end of treatment, which could have
llowed recovery from acute side-effects, whether surgi-
al or medical: treatment-related differences on the various
oL items during the acute phase may have regressed during
ecovery [15,16].
Finally, the criteria adopted in this QoL questionnaire,
nd which we considered relevant to our patients’ quality
f life, may not be the criteria of good quality of life from
he point of view of the patients themselves. Physicians and
atients probably have different ideas of the latter’s quality
f life [17]. Other criteria such as depressive syndrome and
atients’ age and social environment probably also impact
uality of life [18].
In the present study, results differed between laryngeal
nd hypopharyngeal cancer, fairly systematically in favor
f conservative treatment in the latter but without sys-
ematic difference in the former. One reason may be that
urgery for hypopharyngeal carcinoma is more mutilating
ith respect to the mucosa and muscles, with consequently
reater functional sequelae. The proportion of locally more
volved tumors in the surgery group cannot account for
he results as a whole, as it was comparable in the two
ocation groups (larynx/hypopharynx). Likewise, age and
T
p
ont 25th and 75th percentiles, and median. The lower the score,
w response homogeneity.
erroni correction).
ex-ratio tended to differ between treatment groups (for
oth locations), but were generally comparable between the
wo locations, with a higher proportion of female patients
nd a lower median age in the conservative treatment
roup.
The study had several limitations. Analysis was ret-
ospective and compared two non-randomized groups.
ertain treatment features could not be controlled, such
s: phonatory implantation; unilateral, bilateral, func-
ional or radical lymph-node dissection in the surgery
roup; or radiation dose, intensity-modulated radiation
elivery, and the rhythm and dosage adaptations of
he chemotherapy courses. Moreover, the conservative
reatment group included different organ-conservation
rotocols, but sample-size precluded sub-group analysis.
inally, the interval following end of treatment ranged from
ne to 11 years, constituting a further study limitation.
onclusionhere was little difference in quality of life between
atients with laryngectomy or organ conservation. Quality
f life was impaired in all cases, with conservative versus
eal
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[18] Babin E, Sigston E, Hitier M, et al. Quality of life inQuality of life in patients treated for advanced hypopharyng
surgical management affecting different aspects. Long-term
prospective studies could assess and specify the differences
in quality of life associated with these two forms of treat-
ment.
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